GLP-1 Receptor Agonists and Lean Mass
There is a lot of misinformation about GLP-1RAs and lean mass loss! How much is your muscle actually at risk?
Adolescent GLP-1 Receptor Agonists
Adolescent obesity affects 19.7% of youth in the U.S., and Glucagon-like Peptide Receptor Agonists are now widely used for this indication. However, the developmental and long-term consequences when used during this critical period of growth are unknown.
